GlassScriptPhysician profile
Anthony C Feghali
NPI 1134486509
$143,150.71
in general payments reported to CMS, 2019-2025
22 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,915 · 2020: $910 · 2021: $2,984 · 2022: $16K · 2023: $43K · 2024: $43K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Travel and Lodging: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $15K · Honoraria: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,814.00 |
| Travel and Lodging | $24,587.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,308.00 |
| Food and Beverage | $14,995.21 |
| Honoraria | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $97,824.81 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Penumbra, INC. | $32,211.85 | 2020-2025 | Indigo System, Penumbra System, Ruby Coil |
| Cook Medical LLC | $2,672.79 | 2019-2025 | Zilver Ptx, Zenith, Icast Covered Stent System, 6mmx22mmx120cm |
| Silk Road Medical, INC. | $1,502.54 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $1,359.00 | 2022-2025 | Mo.Ma Ultra, Amplatz Goose Neck, Telescope |
| Philips North America LLC | $1,329.10 | 2021-2025 | Igt Devices Undivided, (Br5) Peripheral Ivus |
| Hydrocision, INC. | $1,200.00 | 2024 | Tenjet |
| W. L. Gore & Associates, INC. | $871.72 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Convatec INC. | $815.83 | 2021-2023 | |
| Becton, Dickinson and Company | $578.00 | 2022-2025 | Bd Safetyglide, Power-Trialysis |
| Medtronic Vascular, INC. | $515.08 | 2019-2020 | |
| Terumo Medical Corporation | $377.14 | 2024-2025 | Azur Cx Detachable, Glidesheath Slender, Metacross Otw |
| Shape Memory Medical INC. | $335.60 | 2023-2025 | Impede Embolization Plug |
| Boston Scientific Corporation | $329.30 | 2019-2025 | Enroute Transcarotid Stent |
| Centerline Biomedical INC. | $275.29 | 2021-2023 | Iops, Iops Mobile Cart, Iops Software Application |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $227.90 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $137.78 | 2023 | Lutonix Drug Coated Balloon |
| Integra Lifesciences Corporation | $131.48 | 2019 | |
| Bolton Medical INC | $127.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2023 | Xarelto |
| Abbott Laboratories | $107.93 | 2023 | Jeti |
| Inari Medical, INC. | $94.82 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$430,860.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Feghali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.